NCT02661542View on ClinicalTrials.gov

Study of FF-10502-01 in Patients With Advanced Solid Tumors and Lymphomas

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

99

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

November 5, 2020

Study Completion Date

November 5, 2020

Conditions
Solid TumorsLymphomas
Interventions
DRUG

FF-10502-01

Trial Locations (2)

77030

University of Texas MD Anderson Cancer Center, Houston

80218

Sarah Cannon Research Institute at HealthOne, Denver

Sponsors
All Listed Sponsors
lead

Fujifilm Pharmaceuticals U.S.A., Inc.

INDUSTRY